ResearchBib Share Your Research, Maximize Your Social Impacts
Sign for Notice Everyday Sign up >> Login

Erlotinib Associated Trichomegaly In A Patient With Chronic Latanoprost Use

Journal: Journal of Hematology and Oncology Research (Vol.1, No. 4)

Publication Date:

Authors : ; ; ;

Page : 37-41

Keywords : trichomegaly; oncology;

Source : Downloadexternal Find it from : Google Scholarexternal


Trichomegaly is a known adverse effect with the epidermal growth factor receptor inhibitor (EGFRI) and prostaglandin analogue drug classes. We present a chronic Latanoprost user who developed symptomatic trichomegaly subsequent to initiating an EGFRI medication and believe this case offers evidence that the two classes of medications may cause a similar eyelash manifestation through different mechanisms.

Last modified: 2015-12-12 15:40:49